Full-Time
Bioinformatics Scientist
Posted on 3/28/2023
AI-driven precision medicine through clinical and molecular data analysis
Mid
Remote + 2 more
- Experience in cancer genetics, immunology, or molecular biology
- Experience working with next-generation sequencing data
- Self-driven and works well in interdisciplinary teams
- Experience with communicating insights and presenting concepts to a diverse audience
- Demonstrated programming ability
- Background in predictive or prognostic algorithm development
- Strong background in the development of statistical models
- Design and conduct analysis to improve variant calling, classification and analysis systems
- Translate insight from model systems into predictors and classifiers of therapeutic response and prognosis in clinical cancer care
- Collaborate with scientists, and clinicians to design and perform analyses on cancer clinical sequencing data in order to improve quality of care
- Work in interdisciplinary groups of scientists, engineers, and product developers to translate research into clinically actionable insights for our clients
- Develop algorithms used to gain insight into cancer variation through analysis of next generation sequencing data
- Produce high quality and detailed documentation for all projects
- Must have completed a Ph.D. in Cancer Biology or Molecular Biology related to cancer
- Computational skills using R, Bioconductor, and/or Python
Tempus Labs, Inc. is a leader in precision medicine, leveraging artificial intelligence to analyze vast clinical and molecular data, enabling physicians to deliver personalized, data-driven care. The company's advanced machine learning platform and unique solution sets facilitate the discovery, development, and delivery of optimized therapeutic options for patients. With a focus on extensive molecular profiling, Tempus has developed a robust pan-cancer tumor organoid platform and validated a liquid biopsy assay, demonstrating their commitment to transforming personalized patient care and their position at the forefront of the healthcare industry.
Company Stage
Series G
Total Funding
$1.3B
Headquarters
Chicago, Illinois
Founded
2015